Market extends losing streak for third straight session

The Nifty 50 index fell below the 25,200 level.

Market extends losing streak for third straight session

Representative Image (IANS)

The stock market on Friday continued its losing streak for a third consecutive session over concerns of the impact of Trump’s tariffs and a sell-off in IT shares after the TCS Q1FY26 earnings.

The Nifty 50 index fell below the 25,200 level.

Advertisement

At close, the Sensex was down 689.81 points, or 0.83% at 82,500.47, and the Nifty was down 205.40 points, or 0.81% at 25,149.85.

Advertisement

The BSE Midcap index extended the fall for a third day, falling 0.5%, while the BSE Smallcap index shed 0.7%, snapping a two-day gain.

The cumulative market capitalisation of BSE-listed firms dropped to nearly ₹456.7 lakh crore from ₹460 lakh crore in the previous session.

For the entire week, the Sensex and Nifty indices fell by more than a per cent each, down for a second consecutive week.

Among the sectors, almost all indices ended in the red. Some of the key ones with significant losses were Nifty IT down by 1.78%, Auto down by 1.77%, Media down by 1.60%, Oil & Gas down 1.26%, and Realty down by 1.21%.

However, those who posted some gains were Nifty Pharma, up by 0.68%, and FMCG, which was up by 0.51%.

On Nifty50, only 11 stocks managed to end higher. The top gainers were Hindustan Unilever up by 4.63%, SBI Life Insurance Company up 1.37% and Sun Pharmaceutical Industries up by 0.71%.

Further, as many as 39 stocks ended in the red in the Nifty 50 index. TCS was down 3.47%, Mahindra & Mahindra down by 2.92% and Hero MotoCorp down by 2.74%.

Shares of TCS tanked 3.5% following its Q1 earnings, with experts flagging limited clarity on growth prospects for FY26 for the IT major.

Hindustan Unilever jumped up to 5% after the company announced Priya Nair as its new MD & CEO.

Over 120 stocks on the BSE touched their 52-week highs. These included Glenmark Pharma, Asahi India, EID Parry, Ramco Cements, JK Cement, JK Lakshmi Cement, Krishna Institute of Medical Sciences, and Nippon Life India Asset Management, among others.

Advertisement